Skip to main content
TipRanks
Go Ultimate75% OFF

David Sidransky Insider Profile

4 Followers

David Sidransky, Director at Champions Oncology, holds 0.00 shares in Ayala Pharmaceuticals (Ticker: AYLA), holds 139.00 shares in Advaxis (Ticker: ADXS), holds 767.04K shares in Champions Oncology (Ticker: CSBR).

David Sidransky's Trading History

ADXS
Advaxis
Jan 23, 2023―Uninformative Buy―$83.82
AYLA
Ayala Pharmaceuticals
Jan 23, 2023―Uninformative Sell―$0.00
CSBR
Champions Oncology
Oct 14, 2022DirectorUninformative Buy15.31K$3.61M
ORGS
Orgenesis
Jan 11, 2021DirectorInformative Buy1.07K$67.50
IMNPQ
Immune Pharmaceuticals
Jan 12, 2015―Uninformative Buy―$216.99
AKTX
Akari Therapeutics
Jan 02, 2015DirectorUninformative Buy―$372.18K

You May Also Like

David Sidransky insider profile FAQ

What is the percentage of profitable transactions made by David Sidransky?
The percentage of profitable transactions made by David Sidransky is 25%.
What is the average return per transaction made by David Sidransky?
The average return per transaction made by David Sidransky is -32.30%.
What stocks does David Sidransky hold?
David Sidransky holds: CSBR, AKTX, ORGS, AYLA, ADXS, IMNPQ stocks.
What was David Sidransky's most profitable transaction?
David Sidransky’s most profitable transaction was an Informative Sell of ADXS stock on August 10, 2016. The return on the trade was 58.90%.
What is David Sidransky's role in Champions Oncology?
David Sidransky's role in Champions Oncology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.